This move reflects the company's belief in the potential of Bitcoin (BTC) and other currencies to provide a return on investment for shareholders and to provide some hedge against the Canadian dollar.

Tesla faces significant risks in 2025, including declining sales in Europe and China, and potential U.S. market challenges ...

Thousands of U.S. health agency employees were terminated and told it was for poor performance, though they'd received strong ...

D Molecular Therapeutics is undervalued, with its lead candidate 4D-150 showing potential. Click here to find out why I rate ...

From my colleague Adam Feuerstein: Biogen and Stoke Therapeutics have signed a partnership agreement to co-develop and sell ...

Bayer's subsidiary AskBio received approval from the U.S. drug regulator to accelerate the development of its investigational gene therapy to treat moderate-stage Parkinson's disease.

The Trump administration is tearing down both regulations and the federal government that enforces them. The consequences will be enormous.